{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:18:31Z","timestamp":1776820711225,"version":"3.51.2"},"reference-count":45,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["#P30 CA91842"],"award-info":[{"award-number":["#P30 CA91842"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["777377"],"award-info":[{"award-number":["777377"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-119437"],"award-info":[{"award-number":["DK-119437"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL-151328"],"award-info":[{"award-number":["HL-151328"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK-128169"],"award-info":[{"award-number":["DK-128169"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK-52574"],"award-info":[{"award-number":["P30 DK-52574"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 DK020579"],"award-info":[{"award-number":["P30 DK020579"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PID2020-114710RB100"],"award-info":[{"award-number":["PID2020-114710RB100"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030704","name":"Genome Technology Access Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015755","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Hep\u00e1ticas y Digestivas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015755","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"Institute of Clinical and Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014571","name":"Alvin J. Siteman Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030687","name":"Nutrition Obesity Research Center, University of Washington","doi-asserted-by":"publisher","award":["P30 DK056341"],"award-info":[{"award-number":["P30 DK056341"]}],"id":[{"id":"10.13039\/100030687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["P30 DK020579"],"award-info":[{"award-number":["P30 DK020579"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016220","name":"Georgia Clinical and Translational Science Alliance","doi-asserted-by":"publisher","award":["UL1TR002345"],"award-info":[{"award-number":["UL1TR002345"]}],"id":[{"id":"10.13039\/100016220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015008","name":"Department of Industry, Tourism and Trade, Northern Territory Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015008","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajpath.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T04:10:51Z","timestamp":1709093451000},"page":"958-974","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion"],"prefix":"10.1016","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9250-2149","authenticated-orcid":false,"given":"Elizabeth P.","family":"Newberry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-8638","authenticated-orcid":false,"given":"Elizabeth A.","family":"Molitor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6117-2082","authenticated-orcid":false,"given":"Allen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamyar","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5791-2017","authenticated-orcid":false,"given":"Xiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Mato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3166-2229","authenticated-orcid":false,"given":"Nicholas O.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1053\/j.gastro.2015.08.011","article-title":"Genetics of NiTC: heritability of hepatic fibrosis and steatosis based on a prospective twin study","volume":"149","author":"Loomba","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.31229","article-title":"Genetic pathways in nonalcoholic fatty liver disease: insights from systems biology","volume":"72","author":"Sookoian","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"27769","DOI":"10.1074\/jbc.M110.203679","volume":"286","author":"Qin","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1002\/hep.31988","article-title":"Familial hypobetalipoproteinemia: an underrecognized cause of lean NASH","volume":"74","author":"Buryska","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.32427","article-title":"Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles","volume":"76","author":"Martinez-Arranz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s41395-018-0041-8","article-title":"Genetic variants in PNPLA3 and TM6SF2 predispose to the development of hepatocellular carcinoma in individuals with alcohol-related cirrhosis","volume":"113","author":"Stickel","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/hep.28746","article-title":"Nonalcoholic fatty liver disease and metabolic syndrome: shared genetic basis of pathogenesis","volume":"64","author":"Sookoian","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.31771","article-title":"Liver-specific deletion of mouse Tm6sf2 promotes steatosis, fibrosis, and hepatocellular cancer","volume":"74","author":"Newberry","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2014.05.023","article-title":"Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia","volume":"61","author":"Di Filippo","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.28941","article-title":"Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice","volume":"65","author":"Newberry","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1194\/jlr.M800248-JLR200","article-title":"Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice","volume":"49","author":"Minehira","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.ajpath.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"51664","DOI":"10.1074\/jbc.M309377200","article-title":"Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene","volume":"278","author":"Newberry","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1002\/hep.22927","article-title":"Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver disease","volume":"49","author":"Charlton","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/hep.21369","article-title":"Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice","volume":"44","author":"Newberry","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/modpathol.2016.59","article-title":"Hepatic adenomas with synchronous or metachronous fibrolamellar carcinomas: both are characterized by LFABP loss","volume":"29","author":"Graham","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/PAS.0000000000001711","article-title":"Morphologic and molecular findings in myxoid hepatic adenomas","volume":"45","author":"Rowan","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.humpath.2015.12.002","article-title":"Expression of liver fatty acid binding protein in hepatocellular carcinoma","volume":"50","author":"Cho","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"18229","DOI":"10.18632\/oncotarget.7571","article-title":"Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma","volume":"7","author":"Ku","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"G735","DOI":"10.1152\/ajpgi.00202.2003","article-title":"Intestinal lipoprotein assembly in apobec-1-\/- mice reveals subtle alterations in triglyceride secretion coupled with a shift to larger lipoproteins","volume":"285","author":"Xie","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1096\/fj.201801976R","article-title":"Hepatocyte and stellate cell deletion of liver fatty acid binding protein reveals distinct roles in fibrogenic injury","volume":"33","author":"Newberry","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.ajpath.2024.02.005_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib45","series-title":"Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.ajpath.2024.02.005_bib27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/j.gastro.2017.01.015","article-title":"Metabolomic identification of subtypes of nonalcoholic steatohepatitis","volume":"152","author":"Alonso","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1021\/pr201223p","article-title":"Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression","volume":"11","author":"Barr","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ajpath.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jprot.2015.01.019","article-title":"Enhancing metabolomics research through data mining","volume":"127","author":"Martinez-Arranz","year":"2015","journal-title":"J Proteomics"},{"key":"10.1016\/j.ajpath.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","article-title":"Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals","volume":"316","author":"Suppli","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib31","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.M115.659110","article-title":"Microsomal triglyceride transfer protein transfers and determines plasma concentrations of ceramide and sphingomyelin but not glycosylceramide","volume":"290","author":"Iqbal","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ajpath.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"14437","DOI":"10.1074\/jbc.M610725200","article-title":"HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation","volume":"282","author":"Rebouissou","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/MEG.0b013e3282ffd9f8","article-title":"Cryptogenic cirrhosis in a patient with familial hypocholesterolemia due to a new truncated form of apolipoprotein B","volume":"21","author":"Bonnefont-Rousselot","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1161\/ATVBAHA.112.301101","article-title":"A novel APOB mutation identified by exome sequencing cosegregates with steatosis, liver cancer, and hypocholesterolemia","volume":"33","author":"Cefalu","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib36","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1023\/A:1026646618643","article-title":"Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma","volume":"43","author":"Lonardo","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib38","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136215","article-title":"Hepatic lipids promote liver metastasis","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cmet.2018.08.020","article-title":"Inhibition of acetyl-CoA carboxylase by phosphorylation or the inhibitor ND-654 suppresses lipogenesis and hepatocellular carcinoma","volume":"29","author":"Lally","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.ajpath.2024.02.005_bib40","article-title":"Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis","volume":"5","author":"Crudele","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.ajpath.2024.02.005_bib41","doi-asserted-by":"crossref","first-page":"626","DOI":"10.7150\/jca.13837","article-title":"The clinical significance of preoperative serum cholesterol and high-density lipoprotein-cholesterol levels in hepatocellular carcinoma","volume":"7","author":"Jiang","year":"2016","journal-title":"J Cancer"},{"key":"10.1016\/j.ajpath.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1177\/1724600818776838","article-title":"Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients","volume":"33","author":"Carr","year":"2018","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.ajpath.2024.02.005_bib43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.humpath.2020.11.016","article-title":"Hepatocellular adenomas: review of pathological and molecular features","volume":"112","author":"Beaufrere","year":"2021","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ajpath.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-023-00754-7","article-title":"Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment","volume":"20","author":"Llovet","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024000749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024000749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:10:32Z","timestamp":1762081832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024000749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0002944024000749"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.02.005","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impaired Hepatic Very Low-Density Lipoprotein Secretion Promotes Tumorigenesis and Is Accelerated with Fabp1 Deletion","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}